Literature DB >> 25403957

Metalation kinetics of the human α-metallothionein 1a fragment is dependent on the fluxional structure of the apo-protein.

Gordon W Irvine1, Kelly E R Duncan, Meredith Gullons, Martin J Stillman.   

Abstract

Mammalian metallothioneins are cysteine rich metal-binding proteins comprising, when fully metalated, two metal-binding domains: the α-domain binds with M4(II)S(Cys)11 stoichiometry and the β domain binds as M3(II)S(Cys)9 stoichiometry. While the fully metalated species have been widely studied, the metalation of the apoprotein is poorly understood. Key to a description of the metalation pathway(s) is the initial conformation of the apoprotein and the arrangement of the metal-coordinating cysteines prior to metalation. We report the effect of the ill-defined, globular structure of apoMT on metalation rates. In order to overcome the experimental limitations inherent in structural determinations of a fluxional protein we used a detailed analysis of the apo-α-metallothionein conformation based on the differential rate of cysteine modification with benzoquinone. The ESI mass spectral data show the presence of two distinct conformational families: one a folded conformational family at neutral pH and a second an unfolded family of conformations at low pH. The Cd(II) metalation properties of these two conformationally distinct families were studied using stopped-flow kinetics. Surprisingly, the unfolded apoprotein metalated significantly slower than the folded apoprotein, a result interpreted as being due to the longer time required to fold into the cluster structure when the fourth Cd(II) binds. These results provide the first evidence for the role of the structure of the apo-αMT in the metalation reaction pathways and show that cysteine modification coupled with ESI-MS can be used to probe structure in cysteine-rich proteins.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cysteine modification; kinetics; mass spectrometry; metalation; metalloproteins; protein structure

Mesh:

Substances:

Year:  2014        PMID: 25403957     DOI: 10.1002/chem.201404283

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Selective cysteine modification of metal-free human metallothionein 1a and its isolated domain fragments: Solution structural properties revealed via ESI-MS.

Authors:  Gordon W Irvine; Melissa Santolini; Martin J Stillman
Journal:  Protein Sci       Date:  2017-03-01       Impact factor: 6.725

Review 2.  Proteomic High Affinity Zn2+ Trafficking: Where Does Metallothionein Fit in?

Authors:  David H Petering; Afsana Mahim
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

3.  Function of Metallothionein-3 in Neuronal Cells: Do Metal Ions Alter Expression Levels of MT3?

Authors:  Jamie Bousleiman; Alexa Pinsky; Sohee Ki; Angela Su; Irina Morozova; Sergey Kalachikov; Amen Wiqas; Rae Silver; Mary Sever; Rachel Narehood Austin
Journal:  Int J Mol Sci       Date:  2017-05-25       Impact factor: 5.923

Review 4.  Residue Modification and Mass Spectrometry for the Investigation of Structural and Metalation Properties of Metallothionein and Cysteine-Rich Proteins.

Authors:  Gordon W Irvine; Martin J Stillman
Journal:  Int J Mol Sci       Date:  2017-04-26       Impact factor: 5.923

5.  A Simple Metallothionein-Based Biosensor for Enhanced Detection of Arsenic and Mercury.

Authors:  Gordon W Irvine; Swee Ngin Tan; Martin J Stillman
Journal:  Biosensors (Basel)       Date:  2017-03-13

6.  Isolated domains of recombinant human apo-metallothionein 1A are folded at neutral pH: a denaturant and heat-induced unfolding study using ESI-MS.

Authors:  Gordon W Irvine; Natalie Korkola; Martin J Stillman
Journal:  Biosci Rep       Date:  2018-07-18       Impact factor: 3.840

Review 7.  Interplay between Carbonic Anhydrases and Metallothioneins: Structural Control of Metalation.

Authors:  Daisy L Wong; Amelia T Yuan; Natalie C Korkola; Martin J Stillman
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.